Literature DB >> 34622385

Protective Effect of Chitosan Oligosaccharide against Hydrogen Peroxide-Mediated Oxidative Damage and Cell Apoptosis via Activating Nrf2/ARE Signaling Pathway.

Xiaoxia Zhang1, Shuang Liang1, Xiaohan Gao1, Hanchang Huang1, Fengxue Lao1, Xueling Dai2.   

Abstract

Chitosan oligosaccharide (COS), hydrolyzed and deacetylated from chitosan, has been reported to possess varieties of biological activities. Alzheimer's disease (AD) is a multifactorial progressive neurodegenerative disorder characterized by cognitive decline and memory loss, where oxidative stress was reported to be an overwhelming cause of the occurrence of AD. We have previously reported that COS could significantly decrease cell death, ROS generation, and lipid peroxidation, though the potential mechanism was yet to be determined. This study was designed to investigate the neuroprotective effect of COS against hydrogen peroxide (H2O2)-induced oxidative stress and apoptosis in neuronal SH-SY5Y cells. Our results indicated that COS could dose-dependently scavenge H2O2 in the cell-free systems. Accordingly, COS markedly decreased H2O2-induced cell apoptosis and intracellular ROS generation, while increased antioxidant capacity in SH-SY5Y cells. Further, COS significantly reduced the expression of Bax and upregulated Bcl-2. The mRNA and protein expression levels of nuclear Nrf2, heme oxygenase 1 (HO-1), and NAD(P)H: quinone oxidoreductase 1 (NQO1) were significantly increased upon COS treatment. Moreover, Nrf2-siRNA evidently reversed the promotive effect of COS on expression levels of HO-1 and NQO1, and ARE-driven transcriptional activity as determined by double-luciferase reporter gene assay. Besides, COS reversed H2O2-mediated increased phosphorylation of ERK1/2 and p38 MAPK. In conclusion, our findings indicate that COS could protect SH-SY5Y cells from oxidative damage and apoptosis via regulating Nrf2/ARE signaling pathway, which may provide new applications for the prevention and treatment of AD.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Cell apoptosis; Chitosan oligosaccharide; MAPKs; Nrf2; Oxidative stress

Mesh:

Substances:

Year:  2021        PMID: 34622385     DOI: 10.1007/s12640-021-00419-w

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  34 in total

1.  Chitosan oligosaccharides protect rat primary hippocampal neurons from oligomeric β-amyloid 1-42-induced neurotoxicity.

Authors:  Xueling Dai; Ping Chang; Qingzhu Zhu; Wenjuan Liu; Yaxuan Sun; Shigong Zhu; Zhaofeng Jiang
Journal:  Neurosci Lett       Date:  2013-08-30       Impact factor: 3.046

2.  NRF2/ARE pathway negatively regulates BACE1 expression and ameliorates cognitive deficits in mouse Alzheimer's models.

Authors:  Gahee Bahn; Jong-Sung Park; Ui Jeong Yun; Yoon Jee Lee; Yuri Choi; Jin Su Park; Seung Hyun Baek; Bo Youn Choi; Yoon Suk Cho; Hark Kyun Kim; Jihoon Han; Jae Hoon Sul; Sang-Ha Baik; Jinhwan Lim; Nobunao Wakabayashi; Soo Han Bae; Jeung-Whan Han; Thiruma V Arumugam; Mark P Mattson; Dong-Gyu Jo
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-04       Impact factor: 11.205

3.  Involvement of Nrf2-mediated heme oxygenase-1 expression in anti-inflammatory action of chitosan oligosaccharides through MAPK activation in murine macrophages.

Authors:  Jun-Ho Hyung; Chang-Bum Ahn; Boo Il Kim; Kyunghoi Kim; Jae-Young Je
Journal:  Eur J Pharmacol       Date:  2016-11-06       Impact factor: 4.432

Review 4.  Nrf2-Keap1 signaling in oxidative and reductive stress.

Authors:  Ilaria Bellezza; Ileana Giambanco; Alba Minelli; Rosario Donato
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2018-02-27       Impact factor: 4.739

Review 5.  Nrf2-ARE pathway: An emerging target against oxidative stress and neuroinflammation in neurodegenerative diseases.

Authors:  Izaskun Buendia; Patrycja Michalska; Elisa Navarro; Isabel Gameiro; Javier Egea; Rafael León
Journal:  Pharmacol Ther       Date:  2015-11-23       Impact factor: 12.310

Review 6.  Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis.

Authors:  George S Bloom
Journal:  JAMA Neurol       Date:  2014-04       Impact factor: 18.302

7.  Cul3-mediated Nrf2 ubiquitination and antioxidant response element (ARE) activation are dependent on the partial molar volume at position 151 of Keap1.

Authors:  Aimee L Eggler; Evan Small; Mark Hannink; Andrew D Mesecar
Journal:  Biochem J       Date:  2009-07-29       Impact factor: 3.857

Review 8.  Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease.

Authors:  D Allan Butterfield; Barry Halliwell
Journal:  Nat Rev Neurosci       Date:  2019-03       Impact factor: 38.755

9.  Photo-Induced Oxidative Stress Impairs Mitochondrial Metabolism in Neurons and Astrocytes.

Authors:  Elena Berezhnaya; Maria Neginskaya; Anatoly B Uzdensky; Andrey Y Abramov
Journal:  Mol Neurobiol       Date:  2018-01       Impact factor: 5.590

10.  α-Cyperone Attenuates H2O2-Induced Oxidative Stress and Apoptosis in SH-SY5Y Cells via Activation of Nrf2.

Authors:  Bingxu Huang; Juxiong Liu; Shoupeng Fu; Yufei Zhang; Yuhang Li; Dewei He; Xin Ran; Xuan Yan; Jian Du; Tianyu Meng; Xiyu Gao; Dianfeng Liu
Journal:  Front Pharmacol       Date:  2020-04-08       Impact factor: 5.810

View more
  3 in total

1.  [Islet biomimetic microenvironment constructed by chitosan oligosaccharide protects islets from hypoxia-induced damage by reducing intracellular reactive oxygen species].

Authors:  Dongzhi Wang; Yibing Guo; Yan Huang; Biwen Zhu; Haopeng Pan; Zhiwei Wang
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2022-05-15

2.  Anthocyanin Encapsulated Nanoparticles as a Pulmonary Delivery System.

Authors:  Madumani Amararathna; David W Hoskin; H P Vasantha Rupasinghe
Journal:  Oxid Med Cell Longev       Date:  2022-09-10       Impact factor: 7.310

Review 3.  Iron dyshomeostasis and ferroptosis in Alzheimer's disease: Molecular mechanisms of cell death and novel therapeutic drugs and targets for AD.

Authors:  Yuan Zhang; Man Wang; Wenguang Chang
Journal:  Front Pharmacol       Date:  2022-09-16       Impact factor: 5.988

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.